Product Information
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 is a generic product labeled by Endo USA Inc., priced at $1.1322 per EA under NDC 49884078909. Its NADAC has been published 488 times since Apr 19, 2017.
FDA first approved this application on Oct 26, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazideStrength
10; 12.5; 40 mg/1; mg/1; mg/1
Manufacturer
Endo USA Inc.NDC
49884078909
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA206137FDA Approved
10/26/2016
TE Code
AB
On Market Since
10/26/2016
Pharmacological Classes
Price Statistics
The NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has been published 488 times since Apr 19, 2017, and over the history we have for it it has declined 63.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1322 per EA |
|---|---|
| All-time high | $3.2964 (Jul 12, 2017) |
| All-time low | $1.0705 (Sep 20, 2023) |
| 52-week high | $1.6099 |
| 52-week low | $1.1322 |
| Median price | $1.7359 |
| Average price | $1.8067 |
| Largest weekly change | +34.6% (Sep 19, 2018) |
| Weeks tracked | 488 |
| Tracking since | Apr 19, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
The current National Average Drug Acquisition Cost (NADAC) for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, manufactured by Endo USA Inc., is $1.1322 per EA (NDC 49884078909), effective Aug 19, 2026.
How has the price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 changed over time?
Over the history we have for it, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has declined 63.5%. It has been tracked across 488 weekly CMS publications since Apr 19, 2017.
What are the highest and lowest recorded NADAC prices for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
Since Apr 19, 2017, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has ranged from a low of $1.0705 (Sep 20, 2023) to a high of $3.2964 (Jul 12, 2017), with a median of $1.7359 per EA.
Are there cheaper alternatives to OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 (NDC 49884078909) is labeled by Endo USA Inc., and CMS classifies it as a generic product.